Sympatholytics: Alpha-2 agonists

24,673views

Sympatholytics: Alpha-2 agonists

Watch later

Watch later

Diabetes mellitus: Pathology review
Osmoregulation
Cranial nerves
Renin-angiotensin-aldosterone system
Light microscopy and staining methods
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Tobacco use disorder
Introduction to biostatistics
Types of data
Probability
Mean, median, and mode
Range, variance, and standard deviation
Standard error of the mean (Central limit theorem)
Normal distribution and z-scores
Paired t-test
Two-sample t-test
Hypothesis testing: One-tailed and two-tailed tests
One-way ANOVA
Two-way ANOVA
Repeated measures ANOVA
Correlation
Methods of regression analysis
Linear regression
Logistic regression
Spearman's rank correlation coefficient
Mann-Whitney U test
Kappa coefficient
Chi-squared test
Fisher's exact test
Kaplan-Meier survival analysis
Type I and type II errors
Cardiovascular system anatomy and physiology
Coronary circulation
Blood pressure, blood flow, and resistance
Pressures in the cardiovascular system
Measuring cardiac output (Fick principle)
Stroke volume, ejection fraction, and cardiac output
Cardiac contractility
Cardiac preload
Cardiac afterload
Law of Laplace
Cardiac and vascular function curves
Altering cardiac and vascular function curves
Cardiac cycle
Cardiac work
Pressure-volume loops
Changes in pressure-volume loops
Frank-Starling relationship
Microcirculation and Starling forces
Abnormal heart sounds
Normal heart sounds
HIV (AIDS)
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Diarrhea: Clinical
Celiac disease
Ketone body metabolism
Pediatric allergies: Clinical
Phenylketonuria (NORD)
Antituberculosis medications
Diabetes mellitus
Insulins
Hypertension
Hypertension: Clinical
Type III hypersensitivity
Type IV hypersensitivity
Type I hypersensitivity
Type II hypersensitivity
Poliovirus
Gastrointestinal hormones
Cell cycle
Osteoarthritis
Pediatric brain tumors
Adult brain tumors
Pediatric bone tumors: Clinical
Bone tumors: Pathology review
Inflammatory bowel disease: Clinical
Cholinergic receptors
Adrenergic receptors
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Sympathomimetics: Direct agonists
Sympatholytics: Alpha-2 agonists
Adrenergic antagonists: Presynaptic
Adrenergic antagonists: Alpha blockers
Adrenergic antagonists: Beta blockers
Sexually transmitted infections: Clinical
Cell wall synthesis inhibitors: Penicillins
Lung volumes and capacities
Gas exchange in the lungs, blood and tissues
Clostridium botulinum (Botulism)
Dyslipidemias: Pathology review
Lactose intolerance
Glucagon
Cystic fibrosis: Pathology review
MHC class I and MHC class II molecules
Fetal circulation
Hypokalemia: Clinical
Hyperkalemia: Clinical
Anatomy and physiology of the male reproductive system
Anatomy of the male reproductive organs of the pelvis
Anatomy and physiology of the female reproductive system
Anatomy of the female urogenital triangle
Vaginal and vulvar disorders: Pathology review
Iron deficiency anemia
Appendicitis: Clinical
Hyperthyroidism: Pathology review
Hunger and satiety
Thyroid cancer
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Autoimmune polyglandular syndrome type 1 (NORD)
Multiple endocrine neoplasia
Multiple endocrine neoplasia: Pathology review
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Monoamine oxidase inhibitors
Atypical antidepressants
Typical antipsychotics
Atypical antipsychotics
Lithium
Nonbenzodiazepine anticonvulsants
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Psychomotor stimulants
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Thrombolytics
Nervous system anatomy and physiology
Blood brain barrier
Ascending and descending spinal tracts
Pyramidal and extrapyramidal tracts
Dementia: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Hidradenitis suppurativa
Viral hepatitis: Clinical
Cauda equina syndrome
Cervical cancer
Skin cancer
Gastric cancer
Lung cancer
Colorectal cancer
Pancreatic cancer
Skin cancer: Clinical
Breast cancer: Clinical
Cytokines
Intracerebral hemorrhage
Amino acid metabolism
Citric acid cycle
DNA mutations
Rotator cuff tear
Compartment syndrome
Anatomy of the knee joint
Acute intermittent porphyria
Primary sclerosing cholangitis
Primary biliary cholangitis
Drug misuse, intoxication and withdrawal: Alcohol: Pathology review
Substance misuse and addiction: Clinical
Gene regulation
General anesthetics
Retinopathy of prematurity
Erythema multiforme
Papulosquamous skin disorders: Clinical
Psoriasis
DNA damage and repair
Attention deficit hyperactivity disorder
Glycogen storage disorders: Pathology review
Coronary steal syndrome
Anatomy of the coronary circulation
Coronary artery disease: Clinical
ECG cardiac infarction and ischemia
Local anesthetics
Chest trauma: Clinical
Polycystic ovary syndrome
Pediatric vomiting: Clinical
Pediatric ophthalmological conditions: Clinical
BRUE, ALTE, and SIDS: Clinical
Pediatric orthopedic conditions: Clinical
Congenital heart defects: Clinical
Neonatal jaundice: Clinical
Congenital adrenal hyperplasia: Clinical
Thyroid nodules and thyroid cancer: Clinical
Hypothyroidism and thyroiditis: Clinical
Ectoderm
Endoderm
Mesoderm
Breast cancer
Amyloidosis
Coronary artery disease: Pathology review
Introduction to the immune system
Contracting the immune response and peripheral tolerance
Innate immune system
Viral structure and functions
Bone histology
Bone remodeling and repair
Vessels and nerves of the hand
Jaundice: Clinical
Neonatal ICU conditions: Clinical
Jaundice: Pathology review
Stroke: Clinical
Transcription of DNA
Lac operon
Oncogenes and tumor suppressor genes
Epigenetics
Dizziness and vertigo: Clinical
ECG axis
ECG basics
ECG intervals
ECG QRS transition
ECG normal sinus rhythm
ECG rate and rhythm
ECG cardiac hypertrophy and enlargement
Carcinoid syndrome
Cushing syndrome and Cushing disease: Pathology review
Lung cancer and mesothelioma: Pathology review
Lung cancer: Clinical
Imaging features of COVID-19 (LifeBridge Health)
Development of the COVID-19 vaccine
Standards of care for COVID-19 patients
Safety of the COVID-19 vaccines
COVID-19 mutant variants and herd immunity
COVID-19 vaccines: What healthcare providers need to know
Mitosis and meiosis
Amino acids and protein folding
Neurofibromatosis
Drug administration and dosing regimens
Neuron action potential
Gestational trophoblastic disease: Clinical
Physiological changes during exercise
Nitrogen and urea cycle
Fatty acid synthesis
Electron transport chain and oxidative phosphorylation
Cellular structure and function
Carbohydrates and sugars
Glycolysis
Rheumatoid arthritis
Systemic lupus erythematosus
Ischemic stroke
Anatomy of the heart
Headaches: Pathology review
Herpes simplex virus
Neurocutaneous disorders: Pathology review
Temporomandibular joint dysfunction
Pituitary tumors: Pathology review
Anatomy of the blood supply to the brain
Anatomy of the brainstem
Immunodeficiencies: T-cell and B-cell disorders: Pathology review

Transcript

Watch video only

Central anti-adrenergics are a class of medications that’s not very commonly used these days. Their mechanism of action is to target the adrenergic neurons in the central nervous system, and prevent them from effectively releasing the catecholamines: norepinephrine and epinephrine.

So, the nervous system is divided into the central nervous system, so the brain and spinal cord; and the peripheral nervous system, which includes all the nerves that connect the central nervous system to the muscles and organs. The peripheral nervous system can be divided into the somatic nervous system, which controls voluntary movement of our skeletal muscles; and the autonomic nervous system, which controls the involuntary movement of smooth muscles and glands of our organs.

Now, the autonomic nervous system - which includes both the sympathetic and parasympathetic nervous systems - is made up of a relay that includes two neurons. We’ll focus on just the sympathetic nervous system. Signals for the autonomic nervous system start in the hypothalamus, at the base of the brain. Hypothalamic neurons have really long axons that carry signals all the way down to the thoracic and lumbar spinal cord nuclei, where they synapse with preganglionic neuron cell bodies. Here, they release the neurotransmitter norepinephrine, which causes the preganglionic neurons to transmit the signals down their relatively short axon, which exits the central nervous system via the spinal cord. These short nerve fibers reach the nearby sympathetic ganglion, which consists of many postganglionic neuron cell bodies. The postganglionic neurons are also called adrenergic neurons, because they release the neurotransmitter norepinephrine, which is also called noradrenaline; and to a much lesser degree, epinephrine, or adrenaline. These two catecholamines activate the adrenergic receptors on many different organs, which allow the sympathetic nervous system to trigger the fight or flight response that increases the heart rate and blood pressure, as well as slowing digestion. All of this maximizes blood flow to the muscles and brain, and can help you either run away from a threat, or fight it, which is why it’s also called the “fight or flight response.”

Alright, so let’s zoom into the synapse between the hypothalamic neurons and the preganglionic neurons, which can be found throughout the brainstem and spinal cord. The presynaptic terminal contains loads of tiny synaptic vesicles, each of which stores thousands of norepinephrine molecules. But for norepinephrine to be there in the first place, a precursor amino acid, called tyrosine, is taken up by the adrenergic neuron and gets converted to L-dihydroxyphenylalanine, or L-DOPA for short, by an enzyme called tyrosine hydroxylase. Next, L-DOPA is converted by an enzyme called DOPA decarboxylase to dopamine, which is then packaged into the synaptic vesicles. The remaining dopamine will be broken down by a class of enzymes called monoamine oxidases, or MAOs for short. Okay, now once inside the vesicles, dopamine get converted into norepinephrine. And then, whenever the appropriate signal travels down the axon to the axon terminal, these vesicles fuse with the presynaptic membrane in order for norepinephrine to get released (or exocytosed) into the synaptic cleft and take action on the adrenergic receptors of the postsynaptic neuronal membrane. Okay, but this release of norepinephrine is controlled through negative feedback inhibition. So when a pre-synaptic nerve terminal is stimulated to release a bunch of norepinephrine in the synapse, some of it will bind to a special type of receptor called an alpha-2 adrenergic receptor, located on the presynaptic membrane. These alpha-2 receptors then inhibit further release of norepinephrine into the synapse, so the postsynaptic neuron doesn’t get over stimulated.

Alright, so medications that act on adrenergic neurons of the brainstem to inhibit adrenergic signal transmission are called central anti-adrenergics. What these do, is collectively oppose the effects of the sympathetic nervous system. So overall, the heart rate and blood pressure decrease, digestive processes speed up, and the fight-or-flight response gets blocked.

Key Takeaways

Alpha-2 agonists are a class of drugs that bind to alpha-2 adrenergic receptors and activate them, resulting in a range of physiological effects. Alpha-2 adrenergic receptor agonists include clonidine, guanabenz, and guanfacine. These medications stimulate alpha-2 adrenergic receptors on the presynaptic neurons in the CNS, especially those in the medulla. This decreases the release of norepinephrine in the sympathetic neurons, which leads to lower blood pressure. Alpha-2 agonists are used to treat various conditions such as anxiety, depression, attention deficit hyperactivity disorder (ADHD), and pain. Common side effects associated with the use of alpha-2 agonists include dry mouth, constipation, headache, dizziness, drowsiness, and fatigue.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "G-Protein–Coupled Receptors in Heart Disease" Circulation Research (2018)
  5. "α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands" Molecular Neurobiology (2018)
  6. "Alpha-2 Adrenergic Receptor Agonists: A Review of Current Clinical Applications" Anesthesia Progress (2015)
  7. "Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial" The Lancet (2019)